FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2130343873> ?p ?o ?g. }

• W2130343873 endingPage "5214" @default.
• W2130343873 startingPage "5206" @default.
• W2130343873 abstract "Although respiratory syncytial virus (RSV) is the leading cause of serious respiratory tract disease in children, to date no RSV vaccine is available. To produce an effective subunit vaccine, a truncated secreted version of the F protein (ΔF) was expressed in mammalian cells, purified and shown to form trimers. The ΔF protein was then formulated with a CpG oligodeoxynucleotide (ODN) and an innate defense regulator (IDR) peptide in polyphosphazene microparticles (ΔF-MP). Mice immunized either intramuscularly (IM) or intranasally (IN) with ΔF-MP developed significantly higher levels of virus-neutralizing antibodies in the sera and lungs, as well as higher numbers of IFN-γ secreting cells than mice immunized with the ΔF protein alone. In contrast, the IM delivered ΔF induced high production of IL-5 while the IN delivered ΔF did not elicit a measurable immune response. After RSV challenge, essentially no virus and no evidence of immunopathology were detected in mice immunized with ΔF-MP regardless of the route of delivery. While the mice immunized IM with ΔF alone also showed reduced virus replication, they developed enhanced levels of pulmonary IgE, IL-4, IL-5, IL-13 and eotaxin, as well as eosinophilia after challenge. The level of protection induced by the ΔF-MP formulation was equivalent after IM and IN delivery. The efficacy and safety of the ΔF-MP formulation was confirmed in cotton rats, which also developed enhanced immune responses and were fully protected from RSV challenge after vaccination with ΔF-MP. In conclusion, formulation of recombinant ΔF with CpG ODN and IDR peptide in polyphosphazene microparticles should be considered for further evaluation as a safe and effective vaccine against RSV." @default.
• W2130343873 created "2016-06-24" @default.
• W2130343873 creator A5013431958 @default.
• W2130343873 creator A5024408260 @default.
• W2130343873 creator A5035086403 @default.
• W2130343873 creator A5054537882 @default.
• W2130343873 creator A5055650413 @default.
• W2130343873 creator A5065251951 @default.
• W2130343873 creator A5066530115 @default.
• W2130343873 creator A5079330921 @default.
• W2130343873 creator A5084967847 @default.
• W2130343873 creator A5086897683 @default.
• W2130343873 date "2012-07-01" @default.
• W2130343873 modified "2023-10-11" @default.
• W2130343873 title "Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles" @default.
• W2130343873 cites W1547768824 @default.
• W2130343873 cites W1972386091 @default.
• W2130343873 cites W1978680454 @default.
• W2130343873 cites W1982312545 @default.
• W2130343873 cites W1982399722 @default.
• W2130343873 cites W1989501142 @default.
• W2130343873 cites W1990485538 @default.
• W2130343873 cites W1997117545 @default.
• W2130343873 cites W1999631508 @default.
• W2130343873 cites W2031967641 @default.
• W2130343873 cites W2039403758 @default.
• W2130343873 cites W2040377838 @default.
• W2130343873 cites W2048862104 @default.
• W2130343873 cites W2070475814 @default.
• W2130343873 cites W2074150544 @default.
• W2130343873 cites W2102807285 @default.
• W2130343873 cites W2105719981 @default.
• W2130343873 cites W2106058187 @default.
• W2130343873 cites W2106701493 @default.
• W2130343873 cites W2110926211 @default.
• W2130343873 cites W2116702696 @default.
• W2130343873 cites W2118011548 @default.
• W2130343873 cites W2122489686 @default.
• W2130343873 cites W2123817481 @default.
• W2130343873 cites W2134013694 @default.
• W2130343873 cites W2140898182 @default.
• W2130343873 cites W2141139613 @default.
• W2130343873 cites W2144021590 @default.
• W2130343873 cites W2145361317 @default.
• W2130343873 cites W2147684469 @default.
• W2130343873 cites W2154828915 @default.
• W2130343873 cites W2160675125 @default.
• W2130343873 cites W2166720811 @default.
• W2130343873 doi "https://doi.org/10.1016/j.vaccine.2012.06.011" @default.
• W2130343873 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22713718" @default.
• W2130343873 hasPublicationYear "2012" @default.
• W2130343873 type Work @default.
• W2130343873 sameAs 2130343873 @default.
• W2130343873 citedByCount "62" @default.
• W2130343873 countsByYear W21303438732012 @default.
• W2130343873 countsByYear W21303438732013 @default.
• W2130343873 countsByYear W21303438732014 @default.
• W2130343873 countsByYear W21303438732015 @default.
• W2130343873 countsByYear W21303438732016 @default.
• W2130343873 countsByYear W21303438732017 @default.
• W2130343873 countsByYear W21303438732018 @default.
• W2130343873 countsByYear W21303438732019 @default.
• W2130343873 countsByYear W21303438732020 @default.
• W2130343873 countsByYear W21303438732021 @default.
• W2130343873 countsByYear W21303438732022 @default.
• W2130343873 countsByYear W21303438732023 @default.
• W2130343873 crossrefType "journal-article" @default.
• W2130343873 hasAuthorship W2130343873A5013431958 @default.
• W2130343873 hasAuthorship W2130343873A5024408260 @default.
• W2130343873 hasAuthorship W2130343873A5035086403 @default.
• W2130343873 hasAuthorship W2130343873A5054537882 @default.
• W2130343873 hasAuthorship W2130343873A5055650413 @default.
• W2130343873 hasAuthorship W2130343873A5065251951 @default.
• W2130343873 hasAuthorship W2130343873A5066530115 @default.
• W2130343873 hasAuthorship W2130343873A5079330921 @default.
• W2130343873 hasAuthorship W2130343873A5084967847 @default.
• W2130343873 hasAuthorship W2130343873A5086897683 @default.
• W2130343873 hasConcept C104317684 @default.
• W2130343873 hasConcept C136449434 @default.
• W2130343873 hasConcept C150194340 @default.
• W2130343873 hasConcept C159047783 @default.
• W2130343873 hasConcept C159654299 @default.
• W2130343873 hasConcept C190727270 @default.
• W2130343873 hasConcept C203014093 @default.
• W2130343873 hasConcept C22070199 @default.
• W2130343873 hasConcept C22801619 @default.
• W2130343873 hasConcept C2522874641 @default.
• W2130343873 hasConcept C2777863537 @default.
• W2130343873 hasConcept C2780355102 @default.
• W2130343873 hasConcept C2780727368 @default.
• W2130343873 hasConcept C2780813555 @default.
• W2130343873 hasConcept C2780868878 @default.
• W2130343873 hasConcept C55493867 @default.
• W2130343873 hasConcept C86803240 @default.
• W2130343873 hasConcept C8891405 @default.
• W2130343873 hasConceptScore W2130343873C104317684 @default.
• W2130343873 hasConceptScore W2130343873C136449434 @default.
• W2130343873 hasConceptScore W2130343873C150194340 @default.

• next